Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Review of the European Hematology Association (EHA) 2025 Congress
7
Mins
July 2025
THE 30ᵗʰ EUROPEAN Hematology Association (EHA) Congress was held in the beautiful city of Milan, Italy from the 12ᵗʰ–15ᵗʰ of June 2025…
Read more
7
Mins
24 Jul 2025
Review of the European Hematology Association (EHA) 2025 Congress
THE 30ᵗʰ EUROPEAN Hematology Association (EHA) Congress was held in the beautiful city of Milan, Italy from the 12ᵗʰ–15ᵗʰ of June 2025…
4
Mins
24 Jul 2025
Prognostic Assessment in AL Amyloidosis
Systemic light chain (AL) amyloidosis is a rare plasma cell dyscrasia characterised by the extracellular deposition of misfolded Ig light…
3
Mins
24 Jul 2025
Putting Patients First in Haematology
During the Specialized Working Group session, ‘Quality of Life and Symptoms: Promoting Connection Between Patients and Clinicians’, which…
4
Mins
24 Jul 2025
EHA 2025 Highlights in Acute Lymphoblastic Leukemia
The most important advances in Ph-negative ALL come from the incorporation of immunotherapy into first-line ALL. In this sense…
4
Mins
24 Jul 2025
Advancing Frontiers in Myeloproliferative Neoplasms
THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…
5
Mins
24 Jul 2025
MRD in Clinical and Regulatory Decisions
THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…
5
Mins
24 Jul 2025
Evolving Endpoint Strategies
SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…
5
Mins
17 Jul 2025
EHA 2025 Interview: Konstanze Döhner
My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…
Loading posts...
1
2
3
…
7
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View